PolyPid PYPD
NASDAQ PYPD
$6.60 +0.29 (+4.60%)
At close: Nov 11, 2026 · 4:00 PM EST

PolyPid (PYPD) Preferred Stock Liabilities (2019 - 2020)

Updated

PolyPid (PYPD) posted Preferred Stock Liabilities of $106.31 million for Q4 2020, unchanged from $106.31 million a year earlier.

Analysis

PolyPid (PYPD) Preferred Stock Liabilities (2019 - 2020) Analysis & Trends

  • In prior years, PolyPid's Preferred Stock Liabilities was $106.31 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 PolyPid 114.87 Mn 83.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 106.31 Mn
Dec 31, 2019 106.31 Mn
API Access

PolyPid Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=PYPD&period=max&api_key=YOUR_API_KEY